1. Home
  2. BJDX

as 11-11-2025 2:05pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Medical Specialities

Nasdaq

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.

Founded: 2015 Country:
United States
United States
Employees: N/A City: ACTON
Market Cap: 3.9M IPO Year: 2021
Target Price: N/A AVG Volume (30 days): 103.5K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -19.86 EPS Growth: N/A
52 Week Low/High: $1.26 - $10.20 Next Earning Date: 11-07-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 55.56%

BJDX Daily Stock ML Predictions

Share on Social Networks: